Entecavir maintained virologic suppression through 3 years of treatment in antiviral-naive HBeAg(+) patients (ETV 022/901)

dc.contributor.author	Yang, Joanna
dc.contributor.author	Kaymakoglu, Sabahattin
dc.contributor.author	Poordad, Fred
dc.contributor.author	Brett-Smith, Helena
dc.contributor.author	Hindes, Robert
dc.contributor.author	Chang, Ting-Tsung
dc.contributor.author	Chao, You-Chen
dc.contributor.author	Cheinquer, Hugo
dc.contributor.author	Pessoa, Mario
dc.contributor.author	Gish, Robert
dc.date.accessioned	2021-03-03T12:11:30Z
dc.date.available	2021-03-03T12:11:30Z
dc.identifier.citation	Chang T., Chao Y., Kaymakoglu S., Cheinquer H., Pessoa M., Gish R., Poordad F., Yang J., Brett-Smith H., Hindes R., "Entecavir maintained virologic suppression through 3 years of treatment in antiviral-naive HBeAg(+) patients (ETV 022/901)", 57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44
dc.identifier.other	vv_1032021
dc.identifier.other	av_2c6ee78c-3726-4090-8ecc-e8002525a7ad
dc.identifier.uri	http://hdl.handle.net/20.500.12627/34572
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Gastroenteroloji-(Hepatoloji)
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	GASTROENTEROLOJİ VE HEPATOLOJİ
dc.title	Entecavir maintained virologic suppression through 3 years of treatment in antiviral-naive HBeAg(+) patients (ETV 022/901)
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	44
dc.contributor.firstauthorID	132847

Files in this item

Files	Size	Format	View
There are no files associated with this item.